REtinal and VIsual Cortical Response in Early PSYchosis

NATerminatedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

January 26, 2022

Primary Completion Date

July 20, 2023

Study Completion Date

July 20, 2023

Conditions
Prodromal SchizophreniaPsychotic EpisodeProdromal SymptomsHealthy Controls
Interventions
DEVICE

Retinaute (BioSerenity)

Wearable device in the form of a virtual reality headset for the recording of electrophysiological measurements such as electroretinogram (ERG) and electrocenphalogram (EEG), ISCEV standards

DEVICE

EEG Headset 64 electrodes (BioSemi)

EEG headset with 64 electrodes for the recording of visual cortical electrophysiological signals

DEVICE

MonPackOne (Metrovision)

"Standard device for the recording of electroretinography (ERG) measurements, ISCEV standards~WARNING : Device used only in 3 healthy controls to address the secondary objective"

Trial Locations (1)

54520

Centre Psychothérapeutique de Nancy, Laxou

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

BioSerenity

INDUSTRY

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

Centre Psychothérapique de Nancy

OTHER

NCT05167396 - REtinal and VIsual Cortical Response in Early PSYchosis | Biotech Hunter | Biotech Hunter